Neutralizing tumor necrosis factor activity leads to remission in patients with refractory noninfectious posterior uveitis.
OBJECTIVE: To evaluate the efficacy and safety of tumor necrosis factor (TNF) inhibition with the p55 TNF receptor fusion protein (TNFr-Ig) for severe sight-threatening noninfectious posterior segment intraocular inflammation. METHODS: Seventeen patients with refractory noninfectious posterior segm...
Main Authors: | Murphy, C, Greiner, K, Plskova, J, Duncan, L, Frost, A, Isaacs, J, Rebello, P, Waldmann, H, Hale, G, Forrester, J, Dick, A |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2004
|
Similar Items
-
Intravitreal Dexamethasone Implants for Refractory Macular Edema in Eyes with Noninfectious Uveitis
by: Eugene Yu-Chuan Kang, et al.
Published: (2021-08-01) -
Adalimumab combined with Dexamethasone intravitreal implant in the treatment of refractory noninfectious uveitis macular edema
by: Sui Yuan, et al.
Published: (2024-01-01) -
An Observational Study in the Real Clinical Practice of the Treatment of Noninfectious Uveitis
by: Mar Esteban-Ortega, et al.
Published: (2024-02-01) -
Case Report: A Promising Treatment Strategy for Noninfectious Uveitis
by: Xiao-Bao Liu, et al.
Published: (2022-01-01) -
Campath-1H therapy in refractory ocular inflammatory disease.
by: Dick, A, et al.
Published: (2000)